| Literature DB >> 22291918 |
Tin Aung1, Dominic Montagu, Karen Schlein, Thin Myat Khine, Willi McFarland.
Abstract
BACKGROUND: Assessing the quality of care provided by individual health practitioners is critical to identifying possible risks to the health of the public. However, existing assessment methods can be inaccurate, expensive, or infeasible in many developing country settings, particularly in rural areas and especially for children. Following an assessment of the strengths and weaknesses of the existing methods for provider assessment, we developed a synthesis method combining components of direct observation, clinical vignettes, and medical mannequins which we have termed "Observed Simulated Patient" or OSP. An OSP assessment involves a trained actor playing the role of a 'mother', a life-size doll representing a 5-year old boy, and a trained observer. The provider being assessed was informed in advance of the role-playing, and told to conduct the diagnosis and treatment as he normally would while verbally describing the examinations. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2012 PMID: 22291918 PMCID: PMC3264601 DOI: 10.1371/journal.pone.0030196
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1OSP testing of a rural provider.
Figure 2An urban provider examining the OSP mannequin.
Summary and Sub-unit evaluations scores for directly observed simulated patients: Reception and diagnosis.
| Questionnaire Item | DO Patient | OSP Mannequin | Possible Score |
| N = 20 | N = 20 | ||
|
| |||
| Q 200 Duration of Fever | 1 | 1 | 1 |
| Q 201 Pattern of Fever | 1 | 1 | 1 |
| Q 202 Patient has diarrhoea | 0.75 | 0.65 | 1 |
| Q 203 Patient has runny nose | 0.4 | 0.55 | 1 |
| Q 204 Patient has cough | 0.95 | 1 | 1 |
| Total Score | 4.1 | 4.2 | 5 |
|
| |||
| Q 205 examine eyes and nail beds | 4 | 3.6 | 4 |
| Q 206 examine Respiratory distress | 0.75 | 0.1 | 1 |
| Q 207 check ability to sit or walk without support | 0 | 0.3 | 2 |
| Q 208 examines whether unable to drink or vomits everything | 1.2 | 1.7 | 2 |
| Q 209 examine lethargic with convulsions, or been unconscious | 0.6 | 1 | 2 |
| Q 210 check passing of black water urine | 0.2 | 1.1 | 2 |
| Total Score | 6.75 | 7.8 | 13 |
|
| |||
| Q 211 Taking Temperature | 4 | 3.8 | 4 |
| Q 212 Counting respiratory rate | 0.4 | 0.4 | 4 |
| Total Score | 4.4 | 4.2 | 8 |
|
| |||
| Q 213 has taken malaria medicines in past 3 days | 1.1 | 0.3 | 2 |
| Q 214 bad response to malaria medicines before | 0.45 | 0 | 3 |
| Total Score | 1.55 | 0.3 | 5 |
|
| |||
| Q 215 administer RDT kit | 5 | 5 | 5 |
| Q 216 Correctly interprets result of RDT kit | 20 | 19 | 20 |
| Q 217 voluntarily inform result of RDT kit | 5 | 5 | 5 |
| Total Score | 30 | 29 | 30 |
|
| 46.8 | 45.5 | 61 |
Figure 3Average Provider scores when diagnosing patients and OSP mannequins.
Twenty providers were scored on their performance diagnosing and treating malaria, first by direct observation with real patients; subsequently using the OSP methodology. Figure 3 shows the providers scored for each of the five diagnosis modules. The weights given to each module were determined through consultation with experts in malaria treatment as described in the text. Possible scores were: Unit 1: History Taking (5); Unit 2: Identify severe signs of malaria (13); Unit 3: Vital Signs (8); Unit 4: Antimalarial drug history (5); Unit 5: Perform Rapid Diagnostic Kit test (30).
Difference in performance when caring for directly observed patients and observed simulated patients.
| Components of care | R Pt (n = 20) | S Pt (n = 20) | t value | Significant level | |||
| History taking | 4.1 | 4.2 | −0.384 | NS | |||
| General examination | 6.75 | 7.8 | −1.961 | NS | |||
| Taking vital signs | 4.4 | 4.2 | 0.567 | NS | |||
| Asking anti-malarial drug history | 1.55 | 0.3 | 2.877 | * | |||
| Perform rapid diagnostic tests | 30 | 29 | 1 | NS | |||
| Total | 46.8 | 45.5 | 1.033 | NS | |||
| * p<0.05 | |||||||
| Expected | |||||||
|
|
| Agreement | Kappa | Std. Err. | Z | Prob>Z | |
| History taking | 91.88% | 92.75% | −0.1207 | 0.2192 | −0.55 | 0.709 | Less agreement |
| General examination | 94.59% | 92.77% | 0.2514 | 0.1942 | 1.29 | 0.0977 | Fair agreement |
| Taking vital signs | 95.82% | 92.96% | 0.4058 | 0.2193 | 1.85 | 0.0321 | Moderate agreement |
| Anti-malarial drug history | 82.8% | 83.4% | −0.0377 | 0.0808 | −0.47 | 0.6797 | Less agreement |
| Perform rapid diagnostic tests | 97.62% | 97.6% | 0 | 0 | 0 | 0.0 | perfect agreement |
| Total | 70.0% | 50.0% | 0.4 | 0.2191 | 1.83 | 0.0339 | Moderate agreement |
Summary and Sub-unit evaluations scores directly observed patients and observed simulated patients: Treatment and referral for malaria positive patients.
| DO Patient | OSP Mannequin | Possible Score | |
| N = 3 | N = 20 | ||
|
| |||
| Q 218 Refer to higher health facility | 1 | 1 | 1 |
| Total Score | 1 | 1 | 1 |
|
| |||
| Q 219 Provider weighs patient | 5 | 4.75 | 5 |
| Q 220 Prescribing correct type of Coartem (Coartem 2) | 5 | 4.75 | 5 |
| Total Score | 10 | 9.5 | 10 |
|
| |||
| Q 221 Correctly advises when and how to give Coartem | 4 | 3.8 | 4 |
| Q 222 Advises for trouble taking solid pills and how to administer | 4 | 3.8 | 4 |
| Q 223 Provider says how long full course is (3 days) | 4 | 3.8 | 4 |
| Q 224 Provider emphasizes importance of taken ALL pills | 5 | 4.75 | 5 |
| Total Score | 17 | 16.15 | 17 |
|
| |||
| Q 225 Provider tells patient to bring child for F/up if the child doesn't get better or get worse | 2.67 | 3.6 | 4 |
| Total Score | 2.67 | 3.6 | 4 |
|
| |||
| Q 300 Advises on importance of early health seeking behavior with trained health provider | 1 | 1.35 | 3 |
| Q 301 Advises on importance of insecticide treated nets for prevention of malaria | 2.67 | 2.4 | 4 |
| Total Score | 3.67 | 3.75 | 7 |
|
| 34.33 | 34 | 39 |
Comparison of Observed Simulated Patients and Existing Quality Measurement Tools.
| Quality Measurement Tool | Measures Knowledge | Measures Practice | Accounts for Case-Mix | Accounts for patient-mix | Hawthorne effects? | Structural limitations |
|
|
| No |
|
| N/A: by design vignettes measure the maximum a provider can do | none |
|
|
|
| No | No | Yes: large Hawthorne effects to begin with; decline with the time spent observing | (a) Hard to observe as “serious” illnesses as most are rare; (b)observer never knows true patient diagnosis |
|
|
|
| No | No | No | Infeasible for private sector: providers don't keep patient charts |
|
|
|
|
|
| No | Limited to: (a) non-infectious diseases; (b) adults only; (c) diseases without obvious physiological symptoms that cannot be mimicked; (d) conditions that don't require invasive exams |
|
|
|
|
|
| unknown | none |